Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Farci

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Clinics in Liver Disease|November 1, 2001
Hepatitis C virus. The importance of viral heterogeneityP Farci
Seminars in Liver Disease|July 15, 2000
Clinical significance of hepatitis C virus genotypes and quasispeciesP Farci, R H Purcell
Clinical and Experimental Rheumatology|November 1, 1995
Immunity elicited by hepatitis C virusP Farci, G Orgiana, R H Purcell
Progress in Clinical and Biological Research|January 1, 1983
Epidemiology and clinical course of delta infection in BritainA S Lok, P Farci, H C Thomas
Journal of Hepatology|April 1, 1987
Delta hepatitis in Lebanon. Prevalence studies and a report on six siblings with chronic delta-positive active hepatitisP Farci, A K Burroughs, H C Thomas, et al.
Progress in Clinical and Biological Research|January 1, 1991
Prevention and treatment of hepatitis delta virus infectionP Karayiannis, J Saldanha, J Monjardino, et al.
Journal of Viral Hepatitis|November 21, 2007
Treatment of chronic hepatitis DP Farci, L Chessa, C Balestrieri, et al.
Minerva Medica|April 1, 1990
[The presence of nucleotide sequences of the hepatitis B virus in the serum of HBsAg-negative blood donors in Sardinia]M E Lai, P Farci, A Puxeddu, et al.
Journal of Viral Hepatitis|July 18, 2006
The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferaseJ Hornberger, P Farci, D Prati, et al.
Natural Product Research|January 24, 2015
Antiviral properties from plants of the Mediterranean floraG Sanna, P Farci, B Busonera, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Clinics in Liver Disease|November 1, 2001
Hepatitis C virus. The importance of viral heterogeneityP Farci
Seminars in Liver Disease|July 15, 2000
Clinical significance of hepatitis C virus genotypes and quasispeciesP Farci, R H Purcell
Clinical and Experimental Rheumatology|November 1, 1995
Immunity elicited by hepatitis C virusP Farci, G Orgiana, R H Purcell
Progress in Clinical and Biological Research|January 1, 1983
Epidemiology and clinical course of delta infection in BritainA S Lok, P Farci, H C Thomas
Journal of Hepatology|April 1, 1987
Delta hepatitis in Lebanon. Prevalence studies and a report on six siblings with chronic delta-positive active hepatitisP Farci, A K Burroughs, H C Thomas, et al.
Progress in Clinical and Biological Research|January 1, 1991
Prevention and treatment of hepatitis delta virus infectionP Karayiannis, J Saldanha, J Monjardino, et al.
Journal of Viral Hepatitis|November 21, 2007
Treatment of chronic hepatitis DP Farci, L Chessa, C Balestrieri, et al.
Minerva Medica|April 1, 1990
[The presence of nucleotide sequences of the hepatitis B virus in the serum of HBsAg-negative blood donors in Sardinia]M E Lai, P Farci, A Puxeddu, et al.
Journal of Viral Hepatitis|July 18, 2006
The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferaseJ Hornberger, P Farci, D Prati, et al.
Natural Product Research|January 24, 2015
Antiviral properties from plants of the Mediterranean floraG Sanna, P Farci, B Busonera, et al.
Pageof 7